Cite

HARVARD Citation

    Pu, Y. et al. (2021). Sono‐Controllable and ROS‐Sensitive CRISPR‐Cas9 Genome Editing for Augmented/Synergistic Ultrasound Tumor Nanotherapy. Advanced materials. 33 (45), p. n/a. [Online]. 
  
Back to record